We are live on
!
Find out more
CP
Catalys Pacific Portfolio holdings
AUM
$229M
1-Year Est. Return
100.3%
This Fund
S&P 500
This Quarter
Est. Return
-9.5%
1 Year Est. Return
+100.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
-$15.6M
(-11%)
Cap. Flow
-$1.37M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HLVX
HilleVax
HLVX
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCM
CIS
AIA
TCA
NIA
SCM
AF
CSIA
Catalys Pacific's Q2 2024 Portfolio in Review
As of Q2 2024, Catalys Pacific held 3 positions worth $132M, down 11% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Catalys Pacific's biggest Q2 2024 reduction was HilleVax, cutting an estimated $1.37M.
- Catalys Pacific's ten largest holdings make up 100% of its $132M portfolio in Q2 2024.
- Catalys Pacific opened 0 new positions and closed 0 in Q2 2024.
- Catalys Pacific's portfolio value fell 11% quarter-over-quarter to $132M.
Based on Catalys Pacific's 13F filing for Q2 2024, filed 13 Aug 2024.